FDA Extends Comment Deadline On Drug Code Proposed Rule, Sets Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
Consumer Healthcare Products Association concerned significant National Drug Code changes suggested in proposed rule could affect OTC monograph drug makers.